Cigarette smoking and short-term addiction treatment outcome

Drug and Alcohol Dependence

Volumn 115, Issue 3, 2011, Pages 161-166

  Harrell, P T ^a,b   Montoya, I D ^a   Preston, K L ^a   Juliano, L M ^b   Gorelick, D A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b AMERICAN UNIVERSITY   (United States)

Author keywords

Cigarettes; Cocaine; Nicotine; Opiates; Opioids; Treatment outcome

Indexed keywords

BUPRENORPHINE;

ADULT; ARTICLE; CIGARETTE SMOKING; COCAINE DEPENDENCE; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTCOME ASSESSMENT; OUTPATIENT CARE; PRIORITY JOURNAL; SECONDARY ANALYSIS; SHORT COURSE THERAPY; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT OUTCOME; URINALYSIS;

ADULT; ANALGESICS, OPIOID; BEHAVIOR, ADDICTIVE; BUPRENORPHINE; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; SMOKING; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 79955773545     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.08.017     Document Type: Article

References (60)

1. Bechtholt A.J., Mark G.P. Enhancement of cocaine-seeking behavior by repeated nicotine exposure in rats. Psychopharmacology 2002, 162:178-185.
2. Brandon T.H., Herzog T.A., Juliano L.M., Irvin J.E., Lazev A.B., Simmons V.N. Pretreatment task persistence predicts smoking cessation outcome. J. Abnorm. Psychol. 2003, 112:448-456.
3. Brandon T.H., Juliano L.M., Copeland A.L. Expectancies for Tobacco Smoking. How Expectancies Shape Experience 1999, American Psychological Association, Washington, DC, US, pp. 263-299. I. Kirsch (Ed.).
4. Budney A.J., Higgins S.T., Hughes J.R., Bickel W.K. Nicotine and caffeine use in cocaine-dependent individuals. J. Subst. Abuse 1993, 5:117-130.
5. Chen K., Kandel D.B. The natural history of drug use from adolescence to the mid-thirties in a general population sample. Am. J. Public Health 1995, 85:41-47.
6. Clemmey P., Brooner R., Chutuape M.A., Kidorf M., Stitzer M. Smoking habits and attitudes in a methadone maintenance treatment population. Drug Alcohol Depend 1997, 44:123-132.
7. Derogatis L.R., Cleary P.A. Factorial invariance across gender for the primary symptom dimensions of the SCL-90. Br. J. Soc. Clin. Psychol. 1977, 16:347-356.
8. Dierker L.C., Avenevoli S., Stolar M., Merikangas K.R. Smoking and depression: an examination of mechanisms of comorbidity. Am. J. Psychiatry 2002, 159:947-953.
9. Epstein D.H., Marrone G.F., Heishman S.J., Schmittner J., Preston K.L. Tobacco, cocaine, and heroin: craving and use during daily life. Addict. Behav. 2010, 35:318-324.
10. Freeman K.B., Woolverton W.L. Self-administration of cocaine and nicotine mixtures by rhesus monkeys. Psychopharmacology (Berlin) 2009, 207:99-106.
11. Friend K.B., Pagano M.E. Changes in cigarette consumption and drinking outcomes: findings from Project MATCH. J. Subst. Abuse Treat. 2005, 29:221-229.
12. Frosch D.L., Shoptaw S., Nahom D., Jarvik M.E. Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals. Exp. Clin. Psychopharmacol. 2000, 8:97-103.
13. Frosch D.L., Stein J.A., Shoptaw S. Using latent-variable models to analyze smoking cessation clinical trial data: an example among the methadone maintained. Exp. Clin. Psychopharmacol. 2002, 10:258-267.
14. Gianoulakis C. Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr. Top. Med. Chem. 2009, 9:999-1015.
15. Gorelick D.A., Gardner E.L., Xi Z.X. Agents in development for the management of cocaine abuse. Drugs 2004, 64:1547-1573.
16. Gorelick D.A., Simmons M.S., Carriero N., Tashkin D.P. Characteristics of smoked drug use among cocaine smokers. Am. J. Addict. 1997, 6:237-245.
17. Guydish J., Passalacqua E., Tajima B., Manser S.T. Staff smoking and other barriers to nicotine dependence intervention in addiction treatment settings: a review. J. Psychol. Drugs 2007, 39:423-433.
18. Haas A.L., Sorensen J.L., Hall S.M., Lin C., Delucchi K., Sporer K., Chen T. Cigarette smoking in opioid-using patients presenting for hospital-based medical services. Am. J. Addict. 2008, 17:65-69.
19. Haile C.N., Kosten T.R., Kosten T.A. Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. Am. J. Drug Alcohol Abuse 2009, 35:161-177.
20. Hansen S.T., Mark G.P. The nicotinic acetylcholine receptor antagonist mecamylamine prevents escalation of cocaine self-administration in rats with extended daily access. Psychopharmacology (Berlin) 2007, 194:53-61.
21. Horger B.A., Giles M.K., Schenk S. Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine. Psychopharmacology (Berlin) 1992, 107:271-276.
22. Hurt R.D., Offord K.P., Croghan I.T., Gomez-Dahl L., Kottke T.E., Morse R.M., Melton L.J. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA 1996, 275:1097-1103.
23. Kalman D. Smoking cessation treatment for substance misusers in early recovery: a review of the literature and recommendations for practice. Subst. Use Misuse 1998, 33:2021-2047.
24. How Expectancies Shape Experience 1999, American Psychological Association, Washington, DC, US.
25. Kohn C.S., Tsoh J.Y., Weisner C.M. Changes in smoking status among substance abusers: baseline characteristics and abstinence from alcohol and drugs at 12-month follow-up. Drug Alcohol Depend 2003, 69:61-71.
26. Lemon S.C., Friedmann P.D., Stein M.D. The impact of smoking cessation on drug abuse treatment outcome. Addict. Behav. 2003, 28:1323-1331.
27. Leri F., Bruneau J., Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction 2003, 98:7-22.
28. Levin E.D., Mead T., Rezvani A.H., Rose J.E., Gallivan C., Gross R. The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats. Physiol. Behav. 2000, 71:565-570.
29. Lindsay G.B., Rainey J. Psychosocial and pharmacologic explanations of nicotine's " gateway drug" function. J. Sch. Health 1997, 67:123-126.
30. McDonald C.A., Roberts S., Descheemaeker N. Intentions to quit smoking in substance-abusing teens exposed to a tobacco program. J. Subst. Abuse Treat 2000, 18:291-308.
31. Mello N.K., Lukas S.E., Mendelson J.H. Buprenorphine effects on cigarette smoking. Psychopharmacology (Berlin) 1985, 86:417-425.
32. Meyer T.J., Lin M.M., Brown L.S. Nicotine dependence and depression among methadone maintenance patients. J. Natl. Med. Assoc. 1996, 88:800-804.
33. Moeller F.G., Dougherty D.M. Impulsivity and substance abuse: what is the connection?. Addict. Disord. Treat. 2002, 1:3-10.
34. Montoya I.D., Gorelick D.A., Preston K.L., Schroeder J.R., Umbricht A., Cheskin L.J., Lange W.R., Contoreggi C., Johnson R.E., Fudala P.J. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin. Pharmacol. Ther. 2004, 75:34-48.
35. Morton T.G. Factor analysis, multicollinearity, and regression appraisal models. Appraisal J. 1977, 45:578.
36. Mutschler N.H., Stephen B.J., Teoh S.K., Mendelson J.H., Mello N.K. An inpatient study of the effects of buprenorphine on cigarette smoking in men concurrently dependent on cocaine and opioids. Nicotine Tob. Res. 2002, 4:223-228.
37. Neugebauer N.M., Harrod S.B., Bardo M.T. Nicotine elicits methamphetamine-seeking in rats previously administered nicotine. Drug Alcohol Depend 2010, 106:72-78.
38. Patkar A.A., Lundy A., Leone F.T., Weinstein S.P., Gottheil E., Steinberg M. Tobacco and alcohol use and medical symptoms among cocaine dependent patients. Subst. Abus. 2002, 23:105-114.
39. Patkar A.A., Mannelli P., Peindl K., Murray H.W., Meier B.R., Leone F.T. Changes in tobacco smoking following treatment for cocaine dependence. Am. J. Drug Alcohol Abus. 2006, 32:135-148.
40. Patkar A.A., Vergare M.J., Thornton C.C., Weinstein S.P., Murray H.W., Leone F.T. Nicotine dependence and treatment outcome among African American cocaine-dependent patients. Nicotine Tob. Res. 2003, 5:411-418.
41. Reid M.S., Fallon B., Sonne S., Flammino F., Nunes E.V., Jiang H., Kourniotis E., Lima J., Brady R., Burgess C., Arfken C., Pihlgren E., Giordano L., Starosta A., Robinson J., Rotrosen J. Smoking cessation treatment in community-based substance abuse rehabilitation programs. J. Subst. Abus. Treat. 2008, 35:68-77.
42. Reid M.S., Mickalian J.D., Delucchi K.L., Berger S.P. A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects. Neuropsychopharmacology 1999, 20:297-307.
43. Reid M.S., Mickalian J.D., Delucchi K.L., Hall S.M., Berger S.P. An acute dose of nicotine enhances cue-induced cocaine craving. Drug Alcohol Depend 1998, 49:95-104.
44. Richter K.P., Ahluwalia H.K., Mosier M.C., Nazir N., Ahluwalia J.S. A population-based study of cigarette smoking among illicit drug users in the United States. Addiction 2002, 97:861-869.
45. Robins L.N., Helzer J.E., Ratcliff K.S., Seyfried W. Validity of the diagnostic interview schedule, version II: DSM-III diagnoses. Psychol. Med. 1982, 12:855-870.
46. Roll J.M., Higgins S.T., Budney A.J., Bickel W.K., Badger G.J. A comparison of cocaine-dependent cigarette smokers and non-smokers on demographic, drug use and other characteristics. Drug Alcohol Depend 1996, 40:195-201.
47. Satre D.D., Kohn C.S., Weisner C. Cigarette smoking and long-term alcohol and drug treatment outcomes: a telephone follow-up at five years. Am. J. Addict. 2007, 16:32-37.
48. Sees K.L., Clark H.W. When to begin smoking cessation in substance abusers. J. Subst. Abus. Treat. 1993, 10:189-195.
49. Substance Abuse and Mental Health Services Administration. (2009). Results from the 2008 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434). Rockville, MD. (accessed 10.02.10.). http://www.oas.samhsa.gov/nsduh/2k8nsduh/2k8Results.pdf.
50. Shiffman S. How many cigarettes did you smoke? Assessing cigarette consumption by global report, Time-Line Follow-Back, and ecological momentary assessment. Health Psychol. 2009, 28:519-526.
51. Shoptaw S., Jarvik M.E., Ling W., Rawson R.A. Contingency management for tobacco smoking in methadone-maintained opiate addicts. Addict. Behav. 1996, 21:409-412.
52. Shoptaw S., Rotheram-Fuller E., Yang X., Frosch D., Nahom D., Jarvik M.E., Rawson R.A., Ling W. Smoking cessation in methadone maintenance. Addiction 2002, 97(10):1317.
53. Siqueland L., Crits-Christoph P., Gallop R., Barber J.P., Griffin M.L., Thase M.E., Daley D., Frank A., Gastfriend D.R., Blaine J., Connolly M.B., Gladis M. Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome. Am. J. Addict. 2002, 11:24-40.
54. Spiga R., Martinetti M.P., Meisch R.A., Cowan K., Hursh S. Methadone and nicotine self-administration in humans: a behavioral economic analysis. Psychopharmacology (Berlin) 2005, 178:223-231.
55. Spiga R., Schmitz J., Day J. Effects of nicotine on methadone self-administration in humans. Drug Alcohol Depend 1998, 50:157-165.
56. Sussman S. Smoking cessation among persons in recovery. Subst. Use Misuse 2002, 37:1275-1298.
57. Tanda G., Di Chiara G. A dopamine-μ1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse. Eur. J. Neurosci. 1998, 10:1179-1187.
58. Weinberger A.H., Reutenauer E.L., Vessicchio J.C., George T.P. Survey of clinician attitudes toward smoking cessation for psychiatric and substance abusing clients. J. Addict. Dis. 2008, 27:55-63.
59. Weinberger A.H., Sofuoglu M. The impact of cigarette smoking on stimulant addiction. Am. J. Drug Alcohol Abuse 2009, 35:12-17.
60. Zachariou V., Caldarone B.J., Weathers-Lowin A., George T.P., Elsworth J.D., Roth R.H., Changeux J.P., Picciotto M.R. Nicotine receptor inactivation decreases sensitivity to cocaine. Neuropsychopharmacology 2001, 24:576-589.